Session Details
Panel Discussion 2 Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Long-Term Outcomes and Future Issues
Fri. Nov 20, 2026 10:00 AM - 11:15 AM JST
Fri. Nov 20, 2026 1:00 AM - 2:15 AM UTC
Fri. Nov 20, 2026 1:00 AM - 2:15 AM UTC
Room 2 (2F Convention Hall 2)
Moderator: (Department Colorectal Surgery, Kansai Medical University)
[PD2-1]Mid- to Long-Term Outcomes and NOM-Related Challenges of SCRT Plus CAPOX-Based TNT for Locally Advanced Rectal Cancer: The ENSEMBLE-1 Trial
*Yoshinori Kagawa1 (1. Department of Gastroenterological Surgery, Osaka International Cancer Institute)
[PD2-2]The difficulty of predicting therapeutic efficacy in neoadjuvant therapy, including TNT, for rectal cancer, and its clinical significance.
*Yuji Takayama1 (1. Saitama Medical Center, Jichi Medical University)
[PD2-3]Outcomes of Total Neoadjuvant Therapy for locally advanced rectal cancer
*Tomoko Horie1,2 (1. Koto Hospital)
[PD2-4]Outcomes of Locally Advanced Low Rectal Cancer After Neoadjuvant Therapy: A Propensity Score–Matched Comparison of CRT and TNT
*Noguchi Tatsuki1 (1. Department of Colorectal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research)
[PD2-5]Treatment Strategy After Neoadjuvant Therapy for Rectal Cancer: Limitations of Imaging and Endoscopic Assessment and the Importance of Residual Tumor Burden
*Toshinori Kobayashi1 (1. Department of Surgery, Kansai Medical University Kori Hospital)
[PD2-6]Neoadjuvant Chemotherapy suppress Distant Recurrence in Locally Advanced Lower Rectal Cancer After Achieving R0 Resection.
*Shun Yamaguchi1 (1. Nagasaki University Hospital, Department of Surgery)